4.7 Editorial Material

Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 324, Issue 19, Pages 1937-1938

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2020.19692

Keywords

-

Ask authors/readers for more resources

This Viewpoint reviews systems in place to monitor postlicensure vaccine safety, and recommends harmonizing end points and protocols across vaccine trials and surveillance systems to enable timely identification and reliable evaluation of potential adverse events.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available